Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Ran Gottfried has been appointed to the company's Board of Directors, Perrigo announces Feb. 21. Gottfried is a consultant and director for private and public retailing, distributing, pharmaceutical and telecommunications companies in Israel, the company states. Gottfried also was on the board of the Israeli pharmaceutical company Agis Industries before it was purchased by Perrigo in 2005. He has an "outstanding background in establishing and growing a variety of businesses," Perrigo CEO David Gibbons states...
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.